Skip navigation

Chemical Boronic Acids

1–50 of 520 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. Bortezomib autophagy BNIP3 BNIP3 mutant form inhibits the reaction [Bortezomib results in increased autophagy] 1: Homo sapiens Breast | Tumor Cells, Cultured
14 genes: ABL1 | ATG5 | BECN1 | CTSB | GABARAPL1 | HDAC6 | LGALS8 | PSEN1 | RB1CC1 | SQSTM1 | TP53 | TRP53 | VCP | XBP1
1
2. Bortezomib apoptotic process KRAS KRAS protein promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Pancreas | Cell Line
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
3. Bortezomib cell death Bortezomib results in increased cell death  
6 genes: BNIP3 | CDKN1B | CTSD | FAF1 | HMOX1 | TRAF6
1
4. Bortezomib apoptotic process arsenic trioxide arsenic trioxide promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Bone Marrow | Myeloid Progenitor Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
5. Bortezomib negative regulation of proteasomal protein catabolic process Bortezomib results in increased negative regulation of proteasomal protein catabolic process 1: Homo sapiens HEK293 Cells
2 genes: HSP90AB1 | PSMF1
1
6. Bortezomib apoptotic process IFNA2 [Bortezomib co-treated with IFNA2 protein] results in increased apoptotic process 1: Homo sapiens Urinary Bladder
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
7. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Blood | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
5
8. Bortezomib apoptotic process trichostatin A trichostatin A promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Pancreas | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
9. Bortezomib cell death Organoplatinum Compounds Organoplatinum Compounds inhibits the reaction [Bortezomib results in increased cell death] 1: Homo sapiens Ovary | Cell Line, Tumor
6 genes: BNIP3 | CDKN1B | CTSD | FAF1 | HMOX1 | TRAF6
1
10. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
4
11. Bortezomib apoptotic process sorafenib sorafenib promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens HeLa Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
12. Bortezomib protein ubiquitination Bortezomib results in increased protein ubiquitination 1: Homo sapiens HeLa Cells
46 genes: AKT1 | ANAPC11 | ARRB1 | BARD1 | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BRCA1 | CBL | CCNF | CDC34 | CDC42 | CHFR | CUL1 | CUL3 | DCAF11 | DCAF13 | FBXW7 | HECTD2 | HECW1 | KCMF1 | KCTD10 | KLHDC7B | KLHL20 | LRRC41 | MDM2 | NAIP | NFE2L2 | NUB1 | OS9 | PRKDC | RNF11 | RNF138 | RNF14 | SMURF2 | SOCS3 | SOCS5 | SPSB3 | TNFAIP3 | TRAF6 | TRIML2 | UBR3 | VCP | XIAP | ZNRF2
1
13. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Bronchi | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
14. Bortezomib apoptotic process TNFSF10 TNFSF10 protein promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Prostate | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
15. Bortezomib apoptotic process MYC MYC protein promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
16. Bortezomib apoptotic process vorinostat vorinostat promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens HeLa Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
17. Bortezomib apoptotic process sorafenib sorafenib promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Neuroglia | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
18. Bortezomib apoptotic process Cisplatin Cisplatin promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
19. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Monocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
20. Bortezomib positive regulation of apoptotic process arsenic trioxide | PMAIP1 PMAIP1 protein promotes the reaction [[Bortezomib co-treated with arsenic trioxide] results in increased positive regulation of apoptotic process] 1: Homo sapiens Cell Line, Tumor
88 genes: ABL1 | ACE | ADM | AIFM1 | AIFM2 | AKT1 | ALOX12 | ATF4 | ATM | BAK1 | BARD1 | BAX | BBC3 | BCL2L1 | BCL2L11 | BCL6 | BID | BIK | BIN1 | BNIP3 | CASP12 | CASP2 | CASP3 | CASP6 | CASP8 | CASP9 | CCAR1 | CLU | CTNNB1 | DDIT3 | DIABLO | DNM2 | E2F1 | EIF5A | ERCC3 | ESR2 | FAF1 | FAS | FASLG | FLCN | FOXA1 | GADD45A | GADD45B | GADD45G | GSK3B | GZMA | HIF1A | HMOX1 | HTRA2 | IL6 | ITGA6 | JUN | KLRK1 | MAP2K4 | MAP2K6 | MAPK8 | MAPK9 | MIR21 | MLLT11 | MMP9 | NOTCH2 | NUPR1 | OBSCN | OSGIN1 | PAWR | PDGFRB | PHLDA1 | PMAIP1 | PPP1R15A | PRKCD | PRKDC | PSEN1 | PTGS2 | RELA | RIPK1 | SNCA | SQSTM1 | STK4 | SUDS3 | TCF7L2 | TLR4 | TNF | TNFSF10 | TP53 | TRAF6 | TRIO | TRP53 | WT1
1
21. Bortezomib apoptotic process BCL2 | TNFSF10 BCL2 protein inhibits the reaction [TNFSF10 protein promotes the reaction [Bortezomib results in increased apoptotic process]] 1: Homo sapiens Thyroid Gland | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
22. Bortezomib apoptotic DNA fragmentation TNFRSF10B | TNFSF10 TNFRSF10B mutant form inhibits the reaction [TNFSF10 protein promotes the reaction [Bortezomib results in increased apoptotic DNA fragmentation]] 1: Homo sapiens Lung | Cell Line, Tumor 1 gene: CASP3 1
23. Bortezomib cell proliferation Curcumin Bortezomib promotes the reaction [Curcumin results in decreased cell proliferation] 1: Homo sapiens Plasma Cells | Cell Line, Tumor
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
24. Bortezomib apoptotic process sorafenib Bortezomib promotes the reaction [sorafenib results in increased apoptotic process] 1: Homo sapiens Lung | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
25. Bortezomib apoptotic process vorinostat [Bortezomib co-treated with vorinostat] results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
26. Bortezomib apoptotic process vorinostat [vorinostat co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens Lung | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
27. Bortezomib apoptotic process vorinostat vorinostat promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens T-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
28. Bortezomib apoptotic process CASP2 CASP2 mutant form inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Plasma Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
29. Bortezomib cell proliferation Depsipeptides [Depsipeptides co-treated with Bortezomib] results in decreased cell proliferation 1: Homo sapiens Killer Cells, Natural
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
30. Bortezomib cell proliferation TNFRSF10B | TNFSF10 TNFRSF10B mutant form affects the reaction [TNFSF10 protein promotes the reaction [Bortezomib results in decreased cell proliferation]] 1: Homo sapiens Lung | Cell Line, Tumor
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
31. Bortezomib cell proliferation gambogic acid gambogic acid promotes the reaction [Bortezomib results in decreased cell proliferation] 1: Homo sapiens Hep G2 Cells
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
32. Bortezomib response to oxidative stress Bortezomib results in increased response to oxidative stress 1: Homo sapiens Larynx | Cell Line, Tumor
33 genes: ABCC1 | ABCC2 | ABL1 | AIFM1 | AKT1 | BCL2 | BCL2L1 | CYCS | DDIT3 | ERCC3 | G6PD | GSR | HMOX1 | HMOX2 | MAP2K1 | MBL2 | MMP9 | MUTYH | NFKB1 | NQO1 | PRKCD | PRNP | PSEN1 | PSMB5 | PTGS2 | RRM2B | SDHC | SELENOK | SOD2 | TLR4 | TP53 | TRP53 | TXN2
1
33. Bortezomib cell proliferation lapatinib Bortezomib promotes the reaction [lapatinib results in decreased cell proliferation] 1: Homo sapiens Breast | Cell Line, Tumor
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
34. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Blood Cells | Tumor Cells, Cultured
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
35. Bortezomib apoptotic process RELA RELA protein inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Kidney | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
36. Bortezomib positive regulation of blood coagulation Dexamethasone | F3 | lenalidomide F3 protein affects the reaction [[Dexamethasone co-treated with lenalidomide co-treated with Bortezomib] results in increased positive regulation of blood coagulation] 1: Homo sapiens Blood Vessels | Endothelial Cells | Cell Line
2 genes: NFE2L2 | SERPINE1
1
37. Bortezomib apoptotic process Simvastatin Simvastatin promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
38. Bortezomib regulation of mitochondrial membrane potential alvocidib [alvocidib co-treated with Bortezomib] results in decreased regulation of mitochondrial membrane potential 1: Homo sapiens Blood | Cell Line, Tumor
5 genes: BAK1 | BAX | BCL2 | BCL2L1 | SOD2
1
39. Bortezomib cell proliferation Doxorubicin Doxorubicin promotes the reaction [Bortezomib results in decreased cell proliferation] 1: Homo sapiens Jurkat Cells
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
40. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Lung | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
41. Bortezomib apoptotic process TNFSF10 [Bortezomib co-treated with TNFSF10 protein] results in increased apoptotic process 1: Homo sapiens Kidney | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
42. Bortezomib apoptotic process arsenic trioxide Bortezomib promotes the reaction [arsenic trioxide results in increased apoptotic process] 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
43. Bortezomib apoptotic process 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | BCL2 [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole co-treated with Bortezomib] inhibits the reaction [BCL2 protein results in decreased apoptotic process] 1: Homo sapiens Blood | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
44. Bortezomib apoptotic process arsenic trioxide | rottlerin rottlerin inhibits the reaction [[arsenic trioxide co-treated with Bortezomib] results in increased apoptotic process] 1: Homo sapiens Myeloid Progenitor Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
45. Bortezomib apoptotic process Sirolimus Sirolimus inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
46. Bortezomib cellular response to unfolded protein Bortezomib results in increased cellular response to unfolded protein 1: Homo sapiens Plasma Cells | Cell Line, Tumor
5 genes: BAK1 | BAX | ERN1 | HSF1 | HSPA1A
1
47. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Jurkat Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
48. Bortezomib apoptotic process TNFSF10 [Bortezomib co-treated with TNFSF10 protein] results in increased apoptotic process 1: Homo sapiens  
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
49. Bortezomib cell proliferation TNFRSF10B TNFRSF10B mutant form inhibits the reaction [Bortezomib results in decreased cell proliferation] 1: Homo sapiens Lung | Cell Line, Tumor
45 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | ZMYND11
1
50. Bortezomib apoptotic process BIRC3 | BRCA1 BIRC3 mutant form inhibits the reaction [[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased apoptotic process] 1: Homo sapiens HeLa Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
1–50 of 520 results.